Trial reportDrug design, development and therapy2026
Effects of Intranasal Dexmedetomidine on the Night Before Surgery on Postoperative Delirium in Elderly Patients Undergoing Total Knee/Hip Arthroplasty. A Parallel-Arm, Randomized Controlled, Non-Inferiority Trial.
Trial report in Drug design, development and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Methodological Considerations Regarding the Interpretation of a Non-Inferiority Trial of Preoperative Intranasal Dexmedetomidine for Postoperative Delirium Prevention [Letter].Drug design, development and therapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: It is crucial to identify preoperative treatment methods that can safely and effectively reduce the incidence of postoperative delirium. Objective: To evaluate whether preoperative intranasal dexmedetomidine administration for preventing postoperative delirium is non-inferior to intravenous dexmedetomidine infusion on the operative day before induction for elderly patients undergoing elective knee/hip arthroplasty. Design: This randomized clinical trial was performed at a tertiary hospital in China between January 10, 2025 to August 30, 2025. The follow-up for the last subject was completed on September 6, 2025. Setting: This was a single center trial. Participants: After qualification screening, 535 patients scheduled for unilateral total knee arthroplasty and total hip arthroplasty under general anesthesia were invited to participate in the study. Ultimately, 316 patients were randomly assigned to the experimental group and the control group. Interventions: Patients were randomized to receive intranasal dexmedetomidine (the night before surgery)+intravenous normal saline (before induction) or intranasal normal saline (the night before surgery)+intravenous dexmedetomidine (before induction). Main Outcomes and Measures: The primary outcome was incidence of postoperative delirium within 3 days after surgery assessed by the Confusion Assessment Method. Results: In the intention-to-treat analysis, the incidence of postoperative delirium within 3 days was 9.5% in experimental group and 7.6% in control group. The rate difference was 0.02 (95% CI: -0.04 to 0.08), meeting the pre-specified non-inferiority criterion ( Conclusions and Relevance: For elderly patients undergoing major joint arthroplasty, intranasal dexmedetomidine administered the night before surgery is non-inferior to pre-induction intravenous infusion for preventing postoperative delirium. The intranasal route offers additional benefits, including improved preoperative sleep, reduced anxiety, and superior hemodynamic stability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.